CSPC Innovation Pharmaceutical: This trade complies with the regulations of Article 4 of the Supervision Requirements for Major Asset Restructurings of Listed Companies in Compliance with the Guidelines for the Supervision of Listed Companies.

SZSI · Jul 24

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

新诺威：关于本次交易符合《上市公司监管指引第9号——上市公司筹划和实施重大资产重组的监管要求》第四条规定的说明

CSPC Innovation Pharmaceutical: This trade complies with the regulations of Article 4 of the Supervision Requirements for Major Asset Restructurings of Listed Companies in Compliance with the Guidelines for the Supervision of Listed Companies.

Risk Disclaimer

Statement